KRS Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,543
| Closed | -$251K | – | 122 |
|
|
2024
Q3 | $251K | Sell |
2,543
-15
| -0.6% | -$1.48K | 0.18% | 103 |
|
|
2024
Q2 | $237K | Buy |
2,558
+20
| +0.8% | +$1.85K | 0.18% | 108 |
|
|
2024
Q1 | $241K | Buy |
2,538
+25
| +1% | +$2.37K | 0.19% | 103 |
|
|
2023
Q4 | $224K | Buy |
+2,513
| New | +$224K | 0.21% | 108 |
|
|
2023
Q3 | – | Sell |
-2,745
| Closed | -$228K | – | 116 |
|
|
2023
Q2 | $228K | Buy |
+2,745
| New | +$228K | 0.23% | 104 |
|
|
2023
Q1 | – | Sell |
-2,533
| Closed | -$210K | – | 115 |
|
|
2022
Q4 | $210K | Buy |
+2,533
| New | +$210K | 0.29% | 101 |
|
|
2022
Q1 | – | Sell |
-560
| Closed | -$62K | – | 371 |
|
|
2021
Q4 | $62K | Buy |
+560
| New | +$62K | 0.05% | 216 |
|